Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATI
Clinical trial NCT05079451 · WITHDRAWN
Trial details
- NCT number
- NCT05079451
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2024-01-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.